Correction to: COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist

被引：0
|
作者：
Timothée Laboux
Jean-Baptiste Gibier
Nicolas Pottier
François Glowacki
Aghilès Hamroun
机构：
[1] University of Lille,Kidney Transplantation and Dialysis Department
[2] CHU Lille,RID
[3] INSERM U1167,AGE
[4] Lille University, Department of Pathology, Pathology Institute
[5] Regional and University Hospital Center of Lille,INSERM UMR
[6] Team Mucins,S1172 Lille, JPARC
[7] Epithelial Differentiation and Carcinogenesis,Jean
[8] CHU Lille,Pierre Aubert Research Center
[9] Translational Research for Diabetes,Toxicology and Genopathy Department
[10] Lille University,INSERM U1190
[11] Paris-Saclay University,CNRS, INSERM
[12] Versailles Saint-Quentin University,Clinical Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM
[13] CESP,undefined
来源：
Journal of Nephrology | 2021年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A correction to this paper has been published: https://doi.org/10.1007/s40620-021-01037-7
引用
收藏
页码：379 / 379
相关论文
共 44 条
  • [41] Risk factors for the in-hospital and 1-year mortality of elderly patients hospitalized due to COVID-19-related pneumonia
    Georgakopoulou, Vasiliki Epameinondas
    Gkoufa, Aikaterini
    Makrodimitri, Sotiria
    Tsakanikas, Aristeidis
    Basoulis, Dimitrios
    Voutsinas, Pantazis M.
    Karamanakos, Georgios
    Eliadi, Irene
    Samara, Stamatia
    Triantafyllou, Maria
    Eleftheriadou, Ioanna
    Kampouropoulou, Olga
    Papageorgiou, Chrysovalantis V.
    Anastasopoulou, Amalia
    Papalexis, Petros
    Trakas, Ilias
    Trakas, Nikolaos
    Spandidos, Demetrios A.
    Steiropoulos, Paschalis
    Sipsas, Nikolaos V.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [42] Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
    Holman, Naomi
    Knighton, Peter
    Kar, Partha
    O'Keefe, Jackie
    Curley, Matt
    Weaver, Andy
    Barron, Emma
    Bakhai, Chirag
    Khunti, Kamlesh
    Wareham, Nicholas J.
    Sattar, Naveed
    Young, Bob
    Valabhji, Jonathan
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10): : 823 - 833
  • [43] ANALYSIS OF RISK FACTORS FOR COVID-19-RELATED FATAL OUTCOME IN 337991 PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS IN 2020-2022 YEARS: RUSSIAN NATIONWIDE RETROSPECTIVE STUDY
    Mokrysheva, Natalya G.
    Shestakova, Marina, V
    Vikulova, Olga K.
    Elfimova, Alina R.
    Isakov, Mikhail A.
    Gins, Nikolai A.
    Deviatkin, Andrei A.
    Dedov, Ivan I.
    DIABETES MELLITUS, 2022, 25 (05): : 404 - 417
  • [44] References 1 Patel P, Hiam L, Sowemimo A, Devakumar D, McKee M. Ethnicity and covid-19. BMJ. 2020;369:m2282. 2 Pareek M, Bangash MN, Pareek N, et al. Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020;395(10234): 1421-1422. 3 Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of COVID-19? BMJ. 2020;369:m1548. 4 Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711-1724. 5 Public Health England. Disparities in the risk and outcomes of COVID-19. 2020. 6 Office for National Statistics. Updating ethnic contrasts in deaths involving the coronavirus (COVID-19), England: 24 January 2020 to 31 March 2021. 2021.
    Irizar, Patricia
    Pan, Daniel
    Kapadia, Dharmi
    Becares, Laia
    Sze, Shirley
    Taylor, Harry
    Amele, Sarah
    Kibuchi, Eliud
    Divall, Pip
    Gray, Laura J.
    Nellums, Laura B.
    Katikireddi, Srinivasa Vittal
    Pareek, Manish
    ECLINICALMEDICINE, 2023, 57
12345